Transanal vs. Robotic Surgery for Rectal Cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two surgical approaches to remove rectal cancer while preserving bowel function. Researchers want to see which method—performed through the anus or with robotic assistance—leads to better outcomes and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newly diagnosed rectal cancer (adenocarcinoma) confirmed by biopsy
- Tumor located within 7 cm of the anus
- Cancer stage T1–T3 with lymph-node involvement, but no distant spread
- Age 18–75 years and able to tolerate surgery (good overall health)
- Bowel sphincter (muscle) can be preserved during surgery
- No prior colorectal cancer, inflammatory bowel disease, or other cancers in past 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two robotic surgery methods for rectal cancer: using one small incision (single-port) versus several small incisions (multi-port). The goal is to see which approach offers better outcomes while preserving the sphincter (the muscle that controls bowel movements).
This trial compares standard chemotherapy to more extensive surgery (total mesorectal excision) for patients whose initial local surgery showed high-risk features like poor differentiation, lymphovascular invasion, or larger tumor size. It aims to find the best treatment to prevent cancer from coming back.
This trial tests a new robotic surgery system for common operations on the colon, rectum, prostate, kidney, bladder, stomach, esophagus, gallbladder, and hiatal hernia. It may offer a less invasive option for patients who need surgery for these conditions.
This trial compares two types of minimally invasive surgery for middle and low rectal cancer: robot-assisted (using a machine) and laparoscopic (using small incisions). The goal is to see which approach offers better outcomes for patients like you.
This study compares two ways of performing rectal cancer surgery: robotic surgery and a newer technique called TaTME (transanal total mesorectal excision). It aims to see which approach has better outcomes for patients. If you're having surgery for rectal cancer, this trial might help you get access to advanced surgical options.
This trial compares two robotic surgery methods for high rectal and sigmoid colon cancer—one that removes the tumor through the anus (NOSES-IV) and the traditional assisted approach. It aims to see which way may lead to better recovery.
Hear when a new Rectal Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.